These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 739695

  • 21. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
    Laburthe M, Rousset M, Chevalier G, Boissard C, Dupont C, Zweibaum A, Rosselin G.
    Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
    [Abstract] [Full Text] [Related]

  • 22. [Effects of chlorpromazine, beta-endorphin and vasoactive intestinal polypeptide on plasma growth hormone levels in unanesthetized rats (author's transl)].
    Wakabayashi I, Miyoshi H, Oomura E, Shizume K.
    Horumon To Rinsho; 1980 Jul; 28(6):633-8. PubMed ID: 7418239
    [No Abstract] [Full Text] [Related]

  • 23. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
    Nakaki T, Nakadate T, Yamamoto S, Kato R.
    J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
    [Abstract] [Full Text] [Related]

  • 24. [Experimental pharmacobronchographic investigations of bronchial motor activity (author's transl)].
    Dobek J.
    Pol Przegl Radiol Med Nukl; 1979 Mar; 43(6):357-66. PubMed ID: 547256
    [No Abstract] [Full Text] [Related]

  • 25. Comparative effects of inhaled isoproterenol and vasoactive intestinal peptide on histamine-induced bronchoconstriction in human subjects.
    Altiere RJ, Küng M, Diamond L.
    Chest; 1984 Jul; 86(1):153-4. PubMed ID: 6203684
    [No Abstract] [Full Text] [Related]

  • 26. Potentiation of the bronchoprotective effects of vasoactive intestinal peptide, isoprenaline, and theophylline against histamine challenge in anaesthetised guinea pigs by adrenomedullin.
    Kanazawa H, Kawaguchi T, Fujii T, Shoji S, Hirata K, Kudoh S, Kurihara N, Yoshikawa J.
    Thorax; 1996 Dec; 51(12):1199-202. PubMed ID: 8994515
    [Abstract] [Full Text] [Related]

  • 27. Role of vasoactive intestinal polypeptide in the adaptation of intestinal smooth muscle cells to mechanical distension.
    Rekik M, Delvaux M, Frexinos J, Bueno L.
    J Pharmacol Exp Ther; 1998 Dec; 287(3):832-8. PubMed ID: 9864261
    [Abstract] [Full Text] [Related]

  • 28. Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive intestinal polypeptide (VIP) [proceedings].
    Dodd J, Kelly JS, Said SI.
    Br J Pharmacol; 1979 May; 66(1):125P. PubMed ID: 454920
    [No Abstract] [Full Text] [Related]

  • 29. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit.
    Hayashi K, Masuda K.
    Jpn J Ophthalmol; 1982 May; 26(4):437-42. PubMed ID: 6187959
    [Abstract] [Full Text] [Related]

  • 30. [Studies on hemodynamics and functions of the pancreas. I. Effect of VIP on normal pancreas (author's transl)].
    Inoue K, Kawano T, Shima K, Kim T, Suzuki T, Tobe T, Yajima H.
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1413-23. PubMed ID: 7441916
    [No Abstract] [Full Text] [Related]

  • 31. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W, Benoist L, Besson J, Duval J.
    C R Seances Acad Sci D; 1980 Mar 24; 290(12):791-3. PubMed ID: 6769606
    [Abstract] [Full Text] [Related]

  • 32. Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects.
    Morice A, Unwin RJ, Sever PS.
    Lancet; 1983 Nov 26; 2(8361):1225-7. PubMed ID: 6139572
    [Abstract] [Full Text] [Related]

  • 33. Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium.
    Ottesen B, Ulrichsen H, Wagner G, Fahrenkrug J.
    Acta Physiol Scand; 1979 Nov 26; 107(3):285-87. PubMed ID: 539459
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of vasoactive intestinal peptide on gastric secretion in the cat.
    Vagne M, Konturek SJ, Chayvialle JA.
    Gastroenterology; 1982 Jul 26; 83(1 Pt 2):250-5. PubMed ID: 6806139
    [Abstract] [Full Text] [Related]

  • 36. [Hypnogenic properties of the vasoactive intestinal polypeptide in rats].
    Riou F, Cespuglio R, Jouvet M.
    C R Seances Acad Sci III; 1981 Nov 30; 293(12):679-82. PubMed ID: 6460548
    [Abstract] [Full Text] [Related]

  • 37. Prostanoid contractions in human isolated pulmonary muscle preparations: inhibition by BAY u3405.
    Norel X, Labat C, Gardiner P, Brink C.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Nov 30; 21A():473-6. PubMed ID: 1825585
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of sodium heparin on actions of various bronchoconstrictors in guinea pig tracheal tissues (author's transl)].
    Kitamura S, Ishihara Y, Sugiyama Y, Kosaka K, Harasawa M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec 30; 16(12):886-90. PubMed ID: 745318
    [No Abstract] [Full Text] [Related]

  • 39. Distinct mechanisms for stimulation of intestinal secretion by vasoactive intestinal peptide (VIP) and glucagon.
    Makhlouf GM.
    Gastroenterology; 1977 Feb 30; 72(2):368-9. PubMed ID: 830592
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.